From: European principles of inhibitor management in patients with haemophilia
1. Awareness of the incidence of inhibitors and risk factors throughout life | |
2. Early recognition and accurate diagnosis | |
3. Optimal organization of care and communication between all stakeholders | |
4. Haemostatic treatment with bypassing agents in inhibitor patients | |
5. Inhibitor eradication by immune tolerance induction (ITI) therapy | |
6. Access to, and optimal preparation for, surgery and other invasive procedures | |
7. Provision of specialist nursing care | |
8. Provision of tailored physiotherapy care and monitoring | |
9. Access to psychosocial support | |
10. Involvement in research and innovation |